Skip to main content

Lympho-plasmapheresis in multiple sclerosis: effect on clinical and immunological parameters

  • Chapter
Immunological and Clinical Aspects of Multiple Sclerosis

Abstract

Numerous works have brought evidence for the role of immune humoral factors and cytotoxic lymphocytes in the physiopathology of acute and progressive phases of multiple sclerosis (MS)1,2. Antibodies against myelin3, oligodendrocytes4 or with demyelinating properties5, immune complexes6 and changes in blood or cerebrospinal fluid of T cell distribution are observed principally during active MS7–9. Also, neuroelectrical blocking IgG antibodies are discovered in MS blood10. Furthermore, fragments of neuro-antigens are episodically released11.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McFarlin, D.E. and McFarland, H.F. (1982). Multiple sclerosis I. N. Engl. J. Med., 307, 1183

    Article  PubMed  CAS  Google Scholar 

  2. McFarlin, D. E. and McFarland, H. F. (1982). Multiple sclerosis II. N. Engl. J. Med., 307, 1246

    Article  PubMed  CAS  Google Scholar 

  3. Lisak, R., Zweiman, B. and Norman, M. (1975). Antimyelin antibodies in neurologic diseases. Arch. Neurol., 32, 163

    Article  PubMed  CAS  Google Scholar 

  4. Abramsky, O., Lisak, R., Silverberg, D., Pleasure, D. and George, J. (1977). Antibodies to Oligodendroglia in patients with multiple sclerosis. N. Engl. J. Med., 297, 1207

    Article  PubMed  CAS  Google Scholar 

  5. Wolfgram, F. and Duquette, I. (1976). Demyelinating antibodies in multiple sclerosis. Neurology, 26, 68

    PubMed  CAS  Google Scholar 

  6. Tachovsky, T., Lisak, R., Koprowski, H., Theofilopoulos, A. and Dixon, F. (1976). Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet, ii, 997

    Article  Google Scholar 

  7. Arnason, B. and Waksman, B. (1980). Immunoregulation in multiple sclerosis. Ann. Neurol, 8, 237

    Article  PubMed  CAS  Google Scholar 

  8. Reinherz, E., Weiner, H., Hauser, S., Cohen, J., Distaso, B. and Schlossman, S. (1980). Loss of suppressor T cells in active multiple sclerosis. N. Engl. J. Med., 303, 125

    Article  CAS  Google Scholar 

  9. Cashman, N., Martin, C., Eizenbaum, J.F. and Degos, J.D. (1982). Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid. J. Clin. Invest, 70, 387

    Article  PubMed  CAS  Google Scholar 

  10. Schauf, C., Schauf, V. and Davis, F.A. (1978). Complement dependent serum neuro-electric blocking activity in multiple sclerosis. Neurology, 28, 426

    PubMed  CAS  Google Scholar 

  11. Cohen, S., Herndon, R. and McKahnn, G. (1976). Radioimmuno-assay of myelin basic protein in spinal fluid: an index of active demyelination. N. Engl. J. Med., 295, 1455

    Article  PubMed  CAS  Google Scholar 

  12. Schauf, C., Stefoski, D., Davis, F. and McLeod, B. (1979). Concerning the application of plasmapheresis to multiple sclerosis. Plasma Therapy, 1, 33

    Google Scholar 

  13. Weiner, H. and Dawson, D. (1980). Plasmapheresis in multiple sclerosis: preliminary study. Neurology, 30, 1029

    PubMed  CAS  Google Scholar 

  14. Dau, P., Petajan, J., Johnson K., Panitch, H. and Bornstein, M. (1980). Plasmapheresis in multiple sclerosis: preliminary findings. Neurology, 30, 1023

    PubMed  CAS  Google Scholar 

  15. Tindall, R., Walker, J., Ehle, A., Near, L., Rollins, J. and Becker, D. (1982). Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone. Neurology, 32, 739

    PubMed  CAS  Google Scholar 

  16. Stefoski, D., Schauf, I., McLeod, B., Haywood, C. and Davis, F. (1982). Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis. Neurology, 32, 904

    PubMed  CAS  Google Scholar 

  17. McFarland, H. and Rose, J. (1982). Lymphocytapheresis in the treatment of multiple sclerosis. Plasma Therapy, 3, 411

    Google Scholar 

  18. Giordano, G., Masland, W., Ketchel, S., Holland, K., Tilmann, K., Wallace, B. and Jones, R. (1982). An investigation of lymphocytapheresis in multiple sclerosis. Plasma Therapy, 3, 417

    Google Scholar 

  19. Kennes, B., Leroy, C.P., Dumont, J.P., Faverly, D., Brohée, D., Jacquy, J., Noël, G. and Nève, P. (1983). Cell mediated immunity in progressive forms of multiple sclerosis treated by lympho-plasmapheresis. In Gonsette, R.E. and Delmotte, P. (eds.). Immunological Aspects of Multiple Sclerosis, chap. P11. (Lancaster: MTP Press)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Kennes, B. et al. (1984). Lympho-plasmapheresis in multiple sclerosis: effect on clinical and immunological parameters. In: Gonsette, R.E., Delmotte, P. (eds) Immunological and Clinical Aspects of Multiple Sclerosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6352-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6352-1_30

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6354-5

  • Online ISBN: 978-94-011-6352-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics